Who is sponsoring NCT07475039?

NCT07475039 is sponsored by University of Florida.

What drugs are being tested in NCT07475039?

Interventions in NCT07475039: Standardized and manualized warm calls from providers trained in the BE training, Standardized and manualized warm calls from providers trained in the BE training + ASIST training.

What condition does NCT07475039 study?

NCT07475039 studies Older Adults (50-90 Years), Mental Health, Depression and Suicide Ideation, Social Functioning, Quality of Life, Thwarted Belongingness, Perceived Burdensomeness.

Is NCT07475039 still recruiting?

NCT07475039 is currently recruiting now. Last updated 16 March 2026.

Last reviewed 2026-03-16 · How we verify

NCT07475039

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Project HOPEFUL: A PN-RCT With Implementation Science

Recruiting now NA Last updated 16 March 2026

What this trial tests

NA trial testing Standardized and manualized warm calls from providers trained in the BE training in Older Adults (50-90 Years) in 400 participants. Currently enrolling.

Timeline

5 September 2025

Primary endpoint
30 August 2030

30 August 2030

Quick facts

Lead sponsor	University of Florida
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	400
Start date	5 September 2025
Primary completion	30 August 2030
Estimated completion	30 August 2030
Sites	1 location across United States

Drugs / interventions tested

Standardized and manualized warm calls from providers trained in the BE training
Standardized and manualized warm calls from providers trained in the BE training + ASIST training

Conditions studied

Older Adults (50-90 Years) — all drugs for Older Adults (50-90 Years) →
Mental Health — all drugs for Mental Health →
Depression and Suicide Ideation — all drugs for Depression and Suicide Ideation →
Social Functioning — all drugs for Social Functioning →

Sponsor

University of Florida

Who can join

55 and older, any sex, with Older Adults (50-90 Years) or Mental Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This PN-RCT replicates and evaluates an 8-week warm calling treatment (i.e. caring contacts) delivered to older adults receiving home and community-based services (HCBS; classified as "homebound") in 20-30 minute call "dosages", across 3 conditions, while adding in implementation science measures at multiple levels. Conditions include 2 treatment (i.e. treatment provided by helpers trained in a standardized and manualized Belongingness and Empathy training grounded in narrative reminiscence and the befriending literature (BE condition), and treatment provided by helpers trained in BE + a standardized, manualized, and evidence based suicide intervention training, the Aging Variant of LivingWorks ASIST (BE + ASIST condition), and 1 control (no treatment during the trial; opportunity to receive treatment after the 8 weeks). At the conclusion of treatment, acceptability, appropriateness, feasibility, useability, and sustainability of the program will be evaluated by interventionists, senior center leadership, and regional leadership.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Older Adults (50-90 Years)

Currently open trials in the same condition.

NCT06894680 — Integrating Depression Care Into HIV Services for Older People With HIV Using a Stepped Care, Task-Sharing Approach. · NA · active not recruiting

Other University of Florida trials

Trials by the same sponsor.

NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07475039 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Florida
Last refreshed: 16 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07475039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing